The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone
A Review on the Clinical Outcome of Chinese Women With Moderate to Severe Symptoms of Genitourinary Syndrome of Menopause (GSM) Treated With Vaginal Dehydroepiandrosterone (DHEA)
Sponsor: Chinese University of Hong Kong
Terminated
inadequate sample and only few patients were prescribed with vaginal DHEA
Other terminated trials from Chinese University of Hong Kong
Other Genitourinary Syndrome of Menopause trials with similar outcome
A observational or N/A phase clinical study on Genitourinary Syndrome of Menopause, this trial is terminated or withdrawn. The trial is conducted by Chinese University of Hong Kong and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Aug 2023 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2022 — Aug 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .